Literature DB >> 24569598

Risk of acute kidney injury after percutaneous coronary interventions using radial versus femoral vascular access: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.

Judith Kooiman1, Milan Seth, Simon Dixon, David Wohns, Thomas LaLonde, Sunil V Rao, Hitinder S Gurm.   

Abstract

BACKGROUND: Transradial percutaneous coronary intervention (PCI [TRI]) does not involve catheter manipulation in the descending aorta, whereas transfemoral PCI (TFI) does. Therefore, the risk of acute kidney injury (AKI) after PCI might be influenced by vascular access site. We compared risks of AKI and nephropathy requiring dialysis (NRD) among patients treated with TRI and TFI. METHODS AND
RESULTS: We included patients across 47 hospitals in Michigan. Primary end point was AKI (serum creatinine increase ≥0.5 mg/dL). Secondary end points were NRD and postprocedural bleeding. Odds ratios (OR) for study end points were calculated for the entire and propensity-matched population, reported as crude, and values adjusted for preprocedural calculated AKI risk. Between 2010 and 2012, a total of 82 225 PCI procedures were performed, of which 8915 were TRI. After adjustment, TRI was associated with a reduction in AKI (OR, 0.76, 95% confidence intervals [0.62-0.92]) and bleeding with a trend toward lower NRD risk. The propensity-matched population consisted of 8857 procedures per group. In this population, TRI was associated with lower adjusted odds of AKI (OR, 0.74; 95% confidence intervals [0.58-0.96]), and bleeding (OR, 0.47; 95% confidence intervals [0.36-0.63]), but no difference in NRD was observed. Although postprocedural bleeding was independently associated with AKI (OR, 2.86; 95% confidence intervals [1.75-4.66]) in the propensity-matched population, the lower odds of AKI was not mediated by a reduction in bleeding with TRI. Sensitivity analysis demonstrated that the observed association between access site and AKI could potentially be explained by a moderately strong unknown confounder.
CONCLUSIONS: The risk of AKI was significantly lower after TRI compared with TFI. This finding needs to be evaluated in randomized controlled trials.

Entities:  

Keywords:  hemorrhage; percutaneous coronary intervention; renal insufficiency

Mesh:

Year:  2014        PMID: 24569598     DOI: 10.1161/CIRCINTERVENTIONS.113.000778

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  21 in total

Review 1.  How to balance risks and benefits in the management of CKD patients with coronary artery disease.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Carlo Guastoni
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

Review 2.  Contrast medium induced acute kidney injury: a narrative review.

Authors:  Valentina Pistolesi; Giuseppe Regolisti; Santo Morabito; Ilaria Gandolfini; Silvia Corrado; Giovanni Piotti; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

3.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

4.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

5.  Acute kidney injury following coronary revascularization procedures in patients with advanced CKD.

Authors:  Abduzhappar Gaipov; Miklos Z Molnar; Praveen K Potukuchi; Keiichi Sumida; Zoltan Szabo; Oguz Akbilgic; Elani Streja; Connie M Rhee; Santhosh K G Koshy; Robert B Canada; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2019-11-01       Impact factor: 5.992

Review 6.  Prevention and Management of AKI in ACS Patients Undergoing Invasive Treatments.

Authors:  Ravi A Thakker; Aiham Albaeni; Haider Alwash; Syed Gilani
Journal:  Curr Cardiol Rep       Date:  2022-08-04       Impact factor: 3.955

7.  Postoperative AKI.

Authors:  Naomi Boyer; Jack Eldridge; John R Prowle; Lui G Forni
Journal:  Clin J Am Soc Nephrol       Date:  2022-06-16       Impact factor: 10.614

8.  Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program.

Authors:  Amit N Vora; Maggie Stanislawski; Gary K Grunwald; Mary E Plomondon; John S Rumsfeld; Thomas M Maddox; Mladen I Vidovich; Walter Woody; Brahmajee K Nallamothu; Hitinder S Gurm; Sunil V Rao
Journal:  J Am Heart Assoc       Date:  2017-04-18       Impact factor: 5.501

9.  Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients.

Authors:  Salma Taha; Fabrizio D'Ascenzo; Claudio Moretti; Pierluigi Omedè; Antonio Montefusco; Richard G Bach; Karen P Alexander; Roxana Mehran; Albert Ariza-Solé; Giuseppe Biondi Zoccai; Fiorenzo Gaita
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-09-28       Impact factor: 1.426

10.  Contrast use in relation to the arterial access site for percutaneous coronary intervention: A comprehensive meta-analysis of randomized trials.

Authors:  Rahman Shah; Anthony Mattox; M Rehan Khan; Chalak Berzingi; Abdul Rashid
Journal:  World J Cardiol       Date:  2017-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.